Association of serum oncostatin M with disease severity and mortality in community-acquired pneumonia with diabetes mellitus

Table 5 Analysis of risk factors affecting the 1-year mortality in diabetes mellitus-community-acquired pneumonia patients

Variable	Univariate analysis		Multivariate analysis
	OR (95%CI)	P value	OR (95%CI)	P value
Age, years	1.094 (1.035-1.156)	0.001	1.070 (1.004-1.141)	0.038
Sex, male	0.699 (0.236-2.073)	0.519
Chronic heart diseases	2.177 (0.724-6.542)	0.166
hypertension	0.960 (0.299-3.078)	0.945
Chronic renal diseases	1.031 (0.108-9.866)	0.979
Cerebrovascular diseases	3.556 (1.162-10.876)	0.026
Chronic pulmonary diseases	1.200 (0.226-6.370)	0.830
ALB (g/L)	0.863 (0.774-0.963)	0.009
Cr (μmol/L)	1.011 (1.003-1.020)	0.010
BUN (mmol/L)	1.218 (1.092-1.359)	< 0.0001	1.183 (1.049-1.333)	0.006
LYM (× 109/L)	0.618 (0.301-1.270)	0.190
NLR	1.043 (1.001-1.077)	0.008
PCT (μg/L)	1.198 (0.951-1.509)	0.125
CRP (mg/L)	1.005 (0.998-1.012)	0.177
IL-6 (pg/mL)	1.001 (0.977-1.026)	0.947
IL-8 (pg/mL)	1.034 (1.007-1.061)	0.013
OSM (pg/mL)	1.006 (1.000-1.012)	0.042	1.008 (1.001-1.014)	0.030

OR: Odds ratio; CI: Confidence interval; ALB: Albumin; Cr: Creatinine; BUN: Blood urea nitrogen; LYM: Lymphocyte; NLR: Neutrophil-to-lymphocyte ratio; PCT: Procalcitonin; IL-6: Interleukin-6; IL-8: Interleukin-8; OSM: Oncostatin M; CRP: C-reactive protein.